| Miss Amanda E Mckinley, CRNA | |
|
105 E Locust Street, Bloomfield, IA 52537-0054 | |
| (641) 664-3602 | |
| (641) 664-3765 |
| Full Name | Miss Amanda E Mckinley |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 13 Years |
| Location | 105 E Locust Street, Bloomfield, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871734582 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | D-115235 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wayne County Hospital | Corydon, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wayne County Hospital | 4082508734 | 24 |
News Archive
W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GORE® TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 - 42 mm and is now available for commercial use in the U.S.
Welichem today announced that the Company has begun to enroll patients in a Phase IIb clinical trial with its lead candidate, WBI-1001. The Phase IIb clinical trial is a double-blinded, placebo-controlled, 12-week-treatment study.
An artificial womb has been successfully used to incubate healthy baby lambs for a period of one week, and researchers hope the technology will one day be able to do the same for extremely premature babies.
Stryker's Communications business unit and Acuitec announced today that they have signed an agreement that will integrate both companies' technologies within the operating room to provide customers with a comprehensive offering that combines in-room integration with desirable workflow solutions.
› Verified 1 days ago
| Entity Name | Jefferson County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881294536 PECOS PAC ID: 9335059575 Enrollment ID: O20031223000606 |
News Archive
W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GORE® TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 - 42 mm and is now available for commercial use in the U.S.
Welichem today announced that the Company has begun to enroll patients in a Phase IIb clinical trial with its lead candidate, WBI-1001. The Phase IIb clinical trial is a double-blinded, placebo-controlled, 12-week-treatment study.
An artificial womb has been successfully used to incubate healthy baby lambs for a period of one week, and researchers hope the technology will one day be able to do the same for extremely premature babies.
Stryker's Communications business unit and Acuitec announced today that they have signed an agreement that will integrate both companies' technologies within the operating room to provide customers with a comprehensive offering that combines in-room integration with desirable workflow solutions.
› Verified 1 days ago
| Entity Name | Wayne County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174599468 PECOS PAC ID: 4082508734 Enrollment ID: O20040212000233 |
News Archive
W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GORE® TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 - 42 mm and is now available for commercial use in the U.S.
Welichem today announced that the Company has begun to enroll patients in a Phase IIb clinical trial with its lead candidate, WBI-1001. The Phase IIb clinical trial is a double-blinded, placebo-controlled, 12-week-treatment study.
An artificial womb has been successfully used to incubate healthy baby lambs for a period of one week, and researchers hope the technology will one day be able to do the same for extremely premature babies.
Stryker's Communications business unit and Acuitec announced today that they have signed an agreement that will integrate both companies' technologies within the operating room to provide customers with a comprehensive offering that combines in-room integration with desirable workflow solutions.
› Verified 1 days ago
| Entity Name | Mercy Medical Center-centerville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528018801 PECOS PAC ID: 9739077652 Enrollment ID: O20040310000762 |
News Archive
W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GORE® TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 - 42 mm and is now available for commercial use in the U.S.
Welichem today announced that the Company has begun to enroll patients in a Phase IIb clinical trial with its lead candidate, WBI-1001. The Phase IIb clinical trial is a double-blinded, placebo-controlled, 12-week-treatment study.
An artificial womb has been successfully used to incubate healthy baby lambs for a period of one week, and researchers hope the technology will one day be able to do the same for extremely premature babies.
Stryker's Communications business unit and Acuitec announced today that they have signed an agreement that will integrate both companies' technologies within the operating room to provide customers with a comprehensive offering that combines in-room integration with desirable workflow solutions.
› Verified 1 days ago
| Entity Name | Davis County Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1942255666 PECOS PAC ID: 3971493040 Enrollment ID: O20061129000182 |
News Archive
W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GORE® TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 - 42 mm and is now available for commercial use in the U.S.
Welichem today announced that the Company has begun to enroll patients in a Phase IIb clinical trial with its lead candidate, WBI-1001. The Phase IIb clinical trial is a double-blinded, placebo-controlled, 12-week-treatment study.
An artificial womb has been successfully used to incubate healthy baby lambs for a period of one week, and researchers hope the technology will one day be able to do the same for extremely premature babies.
Stryker's Communications business unit and Acuitec announced today that they have signed an agreement that will integrate both companies' technologies within the operating room to provide customers with a comprehensive offering that combines in-room integration with desirable workflow solutions.
› Verified 1 days ago
| Entity Name | Van Buren County Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1508810714 PECOS PAC ID: 7214829530 Enrollment ID: O20100908000821 |
News Archive
W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GORE® TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 - 42 mm and is now available for commercial use in the U.S.
Welichem today announced that the Company has begun to enroll patients in a Phase IIb clinical trial with its lead candidate, WBI-1001. The Phase IIb clinical trial is a double-blinded, placebo-controlled, 12-week-treatment study.
An artificial womb has been successfully used to incubate healthy baby lambs for a period of one week, and researchers hope the technology will one day be able to do the same for extremely premature babies.
Stryker's Communications business unit and Acuitec announced today that they have signed an agreement that will integrate both companies' technologies within the operating room to provide customers with a comprehensive offering that combines in-room integration with desirable workflow solutions.
› Verified 1 days ago
| Entity Name | Bloomfield Anesthetists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811091390 PECOS PAC ID: 1557529948 Enrollment ID: O20120214000539 |
News Archive
W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GORE® TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 - 42 mm and is now available for commercial use in the U.S.
Welichem today announced that the Company has begun to enroll patients in a Phase IIb clinical trial with its lead candidate, WBI-1001. The Phase IIb clinical trial is a double-blinded, placebo-controlled, 12-week-treatment study.
An artificial womb has been successfully used to incubate healthy baby lambs for a period of one week, and researchers hope the technology will one day be able to do the same for extremely premature babies.
Stryker's Communications business unit and Acuitec announced today that they have signed an agreement that will integrate both companies' technologies within the operating room to provide customers with a comprehensive offering that combines in-room integration with desirable workflow solutions.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Amanda E Mckinley, CRNA Po Box 54, Bloomfield, IA 52537-0054 Ph: (641) 664-3602 | Miss Amanda E Mckinley, CRNA 105 E Locust Street, Bloomfield, IA 52537-0054 Ph: (641) 664-3602 |
News Archive
W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GORE® TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 - 42 mm and is now available for commercial use in the U.S.
Welichem today announced that the Company has begun to enroll patients in a Phase IIb clinical trial with its lead candidate, WBI-1001. The Phase IIb clinical trial is a double-blinded, placebo-controlled, 12-week-treatment study.
An artificial womb has been successfully used to incubate healthy baby lambs for a period of one week, and researchers hope the technology will one day be able to do the same for extremely premature babies.
Stryker's Communications business unit and Acuitec announced today that they have signed an agreement that will integrate both companies' technologies within the operating room to provide customers with a comprehensive offering that combines in-room integration with desirable workflow solutions.
› Verified 1 days ago
Melissa M Mahon, CRNA/ARNP Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 105 E Locust St, Bloomfield, IA 52537 Phone: 641-664-3602 Fax: 641-664-3765 | |
Valerie K Mckinley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 105 E Locust St, Bloomfield, IA 52537 Phone: 641-664-3602 Fax: 641-664-3765 | |
Mrs. Sara Katherine Mullahy, CRNA, ARNP Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 105 E Locust St, Bloomfield, IA 52537 Phone: 641-664-3602 Fax: 641-664-3765 | |
Jay R Brewer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 105 E Locust St, Bloomfield, IA 52537 Phone: 641-664-3602 Fax: 641-664-3765 | |
Jackie K Lauer, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 505 W Jefferson St, Bloomfield, IA 52537 Phone: 641-664-3602 Fax: 641-664-3765 | |
Mr. Mark James Gallion, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 105 E Locust St, Bloomfield, IA 52537 Phone: 641-664-3602 | |
Marty J Owen, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 505 W Jefferson St, Bloomfield, IA 52537 Phone: 641-664-3602 Fax: 641-664-3765 |